Relay Therapeutics, Inc. (RLAY) News
Track canonical SquawkNews coverage tagged to RLAY, Relay Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
RLAY - Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
RLAY - Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
EQUITY | Sep 01, 2026, 08:46 PM UTC
L
RLAY - Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
RLAY - Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
EARNINGS | Jul 30, 2026, 08:07 PM UTC
L
Private Markets: Chai Discovery, Etched land major rounds
Chai Discovery and Etched secured hundreds of millions in new financing, pushing valuations into multibillion dollar territory and drawing comparisons to publicly traded leaders in their sectors. This week's private comp
EQUITY | Jul 23, 2026, 06:52 PM UTC
L
RLAY Initiated at Buy and $29 PT @ Canaccord
RLAY Initiated at Buy and $29 PT @ Canaccord
EQUITY | Jul 16, 2026, 12:42 PM UTC
L
RLAY Initiated Buy W/$29.00 PT at Canaccord
RLAY Initiated Buy W/$29.00 PT at Canaccord
EQUITY | Jul 16, 2026, 11:54 AM UTC
L
Relay Therapeutics Insider Sold Shares Worth $331,131, According to a Recent SEC Filing
() -- Thomas Catinazzo, Chief Financial Officer, on July 06, 2026, sold 17,717 shares in Relay Therapeutics (RLAY) for $331,131. Following the Form 4 filing with the SEC, Catinazzo has control over a total of 159,744 com
REGULATION | Jul 08, 2026, 09:13 PM UTC